1. Hyperhomocysteinemia is linked to MASLD.
- Author
-
De Matteis, Carlo, Crudele, Lucilla, Di Buduo, Ersilia, Cantatore, Salvatore, Gadaleta, Raffaella Maria, Cariello, Marica, Suppressa, Patrizia, Antonica, Gianfranco, Berardi, Elsa, Graziano, Giusi, and Moschetta, Antonio
- Subjects
- *
CAROTID intima-media thickness , *CAROTID artery ultrasonography , *VITAMIN D , *ATHEROSCLEROTIC plaque , *WAIST circumference - Abstract
• In our cohort, individuals with MASLD showed increased levels of homocysteine (Hcy). • High Hcy levels characterize increased risk for metabolic-associated steatotic liver disease (MASLD) development even when accounting for potentially confounding variables like age and sex. • Identifying patients with hyperhomocysteinemia could help clinicians targeting patients at increased risk of MASLD. Homocysteine (Hcy) levels are elevated in different conditions, including cardiovascular diseases (CVD), diabetes, and metabolic-associated steatotic liver disease (MASLD). In this observational retrospective study, we analyzed Hcy levels in a population of 901 outpatients, considering its putative etiological role in MASLD. A total of 901 outpatients underwent physical and biochemical evaluations. Abdominal and carotid ultrasound were performed to assess liver steatosis, carotid intima-media thickness (IMT) and presence of atherosclerotic plaque. Hyperhomocysteinemia (HHcy) was identified in 140 subjects (16 %). Patients with HHcy showed glucose metabolism impairment (p < 0.001), altered lipid profile (p < 0.001), low Vitamin D levels (p < 0.0001), increased cardiovascular risk (p < 0.001). We then investigated the relationship between Hcy and MASLD (OR=3.6, p < 0.0001), finding that the relationship remained significant also when accounting for confounding variables (age, sex) (OR=3.2, p < 0.0001). Hcy values were significantly higher (p < 0.0001) in patients with MASLD (n = 78, 29.4 ± 10.1μmol/l) compared to those without MASLD (20.4 ± 4.8 1μmol/l). Furthermore, in MASLD patients we found a direct correlation between Hcy level and waist circumference (r = 0.3, p < 0.001) and an inverse correlation with both HDL-c (r =-0.4, p < 0.001) and Vitamin D levels (r =-0.24, p < 0.05). Our data suggest an intriguing scenario whereby HHcy is present in patients with MASLD and is associated to lower vitamin D and altered glucose and lipid profile. Thus, considering Hcy levels may help clinicians with the management of patients with increased MASLD risk. [ABSTRACT FROM AUTHOR]
- Published
- 2025
- Full Text
- View/download PDF